deal  merger  picture: photo to go

DH Corp buys fintech co Fundtech for $1.25b

Israel's Clal Industries sold its stake in Fundtech in 2011, at a company value of only $390 million.

Tue: Tel Aviv 25 up 6.5% in March, 11% in Q1

Bank Hapoalim and Bank Leumi lifted the market today but Delek fell following its financials.

Mukesh Ambani Indian billionaire eyes Israel start-up investments

Mukesh Ambani is seeking start-ups that dovetail with his plans for e-commerce and telecom in India, reports "Bloomberg."

Renting an apartment? Income tax won't exactly help

Families renting a larger home and renting out their smaller home should get a tax break.

Hyperion sale yields profit for Clal Biotech

The sale will increase Clal Biotech's profit by NIS 22.5 million.

AirEuropa AirEuropa launches Israel flights

Tourist class return tickets on the Tel Aviv-Madrid route will cost $390.

Teva  picture: Bloomberg UBS applauds Teva for Auspex acquisition

Analyst Marc Goodman: This is a smart, strategic deal.

shekels Shekel stable against dollar, stronger against euro

FXCM Israel: It is difficult to see a trigger that will cause the exchange rate to break above NIS 4/$, or fall below NIS 3.90/$.

Elsztain, Ben-Moshe picture: Tamar Matzapi IDB Development posts NIS 1b loss

Revenue was stable in 2014, but the group posted large losses on revaluations.

US court rules T-Mobile infringed oti patent

The ruling means that when the case comes to trial the jury will be instructed that the patent was infringed.

Tnuva  picture: Tamar Mitzpi Bright Food finally completes acquisition of Tnuva

Bright Food has transferred NIS 4.78 billion to Apax Partners and Mivtach Shamir.

Mizrahi Meir

Adv., Meir Mizrahi & Co.

Read More >>
BusinessWire
Gali Weinreb Teva gambles on innovation

Teva is betting $3.2 billion on a company with no approved products.

Dorit Salinger Fosun seeks regulator's nod for Phoenix takeover

Chinese company Fosun International wants to buy up to a 52.3% stake in the Israeli insurance company.

Teva Teva launches generic hypertension drug in US

Exforge tablets had annual sales of $409 million in the US, according to IMS data as of January 2015.

Yitzhak Tshuva Delek delays London offering

Delek Group posted a NIS 765 million loss for 2014, and says regulatory uncertainty has halted its plans to list on the London Stock Exchange.

easyJet easyJet inaugurates Tel Aviv-Paris flights

The low cost carrier is operating flights on Mondays, Wednesdays and Saturdays between Ben Gurion and Charles de Gaulle.

Pnina Fishman photo: Tamar Matzapi Can-Fite plummets after psoriasis trial fails

Over 60% was wiped off the coampny's value on Wall Street yesterday.

Amir Scharf Israel tightens forex trading platform regulations

Adv. Amir Scharf discusses the extensive restrictions on trading platforms introduced by the Israel securities Authority.

Teva Teva to acquire Auspex for $3.2b

Teva CEO Erez Vigodman: The acquisition of Auspex is a significant step in strengthening Teva’s leadership position in CNS.

Avi Nissenkorn Histadrut, employers agree even higher minimum wage

The mimimum wage will now rise in four installments to NIS 5,300 by December 2017.

Twitter Facebook Linkedin RSS Newsletters גלובס ועידת שוק ההון